SecurityPTY / PIMCO Corporate & Income Opportunity Fund (72201B101)
Institutional Owners103
Institutional Shares7,081,626
Institutional Value$ 169,524,000 USD

Institutional Stock Ownership and Shareholders

PTY / PIMCO Corporate & Income Opportunity Fund Institutional Ownership

PIMCO Corporate & Income Opportunity Fund (NYSE:PTY) has 103 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 7,081,626 shares. Largest shareholders include Cornerstone Wealth Management, LLC, Morgan Stanley, Cohen & Steers Inc, Commonwealth Equity Services, Llc., Invesco Ltd., Commonwealth Equity Services, Inc, Ameriprise Financial Inc, Bank Of America Corp /de/, Ladenburg Thalmann Financial Services Inc, and UBS Group AG.
PIMCO Corporate & Income Opportunity Fund (NYSE:PTY) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-07-10 13F-HR HOLLENCREST SECURITIES LLC 43,188 41,968 -2.82 731 734 0.41
2018-08-14 13F-HR UBS Group AG 224,410 204,649 -8.81 3,797 3,579 -5.74
2018-02-16 13F-HR/A Commonwealth Equity Services, Inc 341,152 418,822 22.77 5,619 7,028 25.08
2018-08-22 13F-HR Mount Yale Investment Advisors, Llc 12,000 210
2018-08-03 13F-HR Seacrest Wealth Management, Llc 900 900 0.00 15 16 6.67
2018-07-30 13F-HR Parallel Advisors, LLC 400 400 0.00 7 6 -14.29
2017-08-01 13F-HR TRENT CAPITAL MANAGEMENT INC /NC/ 20,551 20,551 0.00 294 338 14.97
2018-08-14 13F-HR Cetera Advisor Networks LLC 0 121,817 0 2,127
2018-08-03 13F-HR Financial Architects, Inc 2,950 2,950 0.00 50 52 4.00
2018-07-12 13F-HR Covenant Asset Management, LLC 40,635 40,635 0.00 688 711 3.34
2018-08-08 13F-HR US BANCORP \DE\ 61,487 64,755 5.31 1,041 1,132 8.74
2018-07-18 13F-HR Fny Investment Advisers, Llc 720 12
2018-08-14 13F-HR UBS ASSET MANAGEMENT AMERICAS INC 505 514 1.78 8,545 8,990 5.21
2018-08-14 13F-HR ROYAL BANK OF CANADA 51,038 59,018 15.64 864 1,032 19.44
2018-07-09 13F-HR Capital Investment Advisors, LLC 23,083 20,282 -12.13 391 355 -9.21
2018-08-13 13F-HR NINE MASTS CAPITAL Ltd 0 24,700 0 432
2018-08-08 13F-HR M&R CAPITAL MANAGEMENT INC 2,000 2,000 0.00 33 34 3.03
2018-08-15 13F-HR Focused Wealth Management, Inc 11,346 11,477 1.15 192 201 4.69
2018-08-03 13F-HR SEI INVESTMENTS CO 4,966 9,775 96.84 84 171 103.57
2018-08-14 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 6,268 4,135 -34.03 106 72 -32.08
2018-07-26 13F-HR Advisornet Financial, Inc 325 945 190.77 5 17 240.00
2018-08-09 13F-HR MARK SHEPTOFF FINANCIAL PLANNING, LLC 70 70 0.00 1 1 0.00
2018-08-13 13F-HR GOULD ASSET MANAGEMENT LLC /CA/ 23,228 23,228 0.00 393 406 3.31
2018-07-19 13F-HR BENJAMIN F. EDWARDS & COMPANY, INC. 3,025 3,025 0.00 51 53 3.92
2018-08-10 13F-HR Cambridge Investment Research Advisors, Inc. 31,030 38,475 23.99 525 673 28.19
2018-08-10 13F-HR CITIGROUP INC 8,387 7,387 -11.92 142 129 -9.15
2018-05-11 13F-HR CITIGROUP INC 18,906 8,387 -55.64 311 142 -54.34
2018-08-14 13F-HR Invesco Ltd. 436,337 424,402 -2.74 7,383 7,423 0.54
2018-08-14 13F-HR MORGAN STANLEY 699,564 836,848 19.62 11,837 14,637 23.65
2018-08-15 13F-HR JANE STREET GROUP, LLC 0 13,669 0 239
2018-08-14 13F-HR LPL Financial LLC 284,880 151,981 -46.65 4,820 2,658 -44.85
2018-08-10 13F-HR Krasney Financial LLC 1,785 1,785 0.00 30 31 3.33
2018-08-09 13F-HR D'Orazio & Associates, Inc. 126 129 2.38 2 2 0.00
2018-08-14 13F-HR Apriem Advisors 0 750 0 13
2018-08-14 13F-HR Squarepoint Ops LLC 0 18,400 0 322
2018-07-24 13F-HR Janney Montgomery Scott LLC 16,950 18,150 7.08 287 317 10.45
2018-07-31 13F-HR Commonwealth Equity Services, Llc. 453,438 458,287 1.07 7,672 8,015 4.47
2018-08-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 246,289 246,289 0.00 4,167 4,167 0.00
2018-07-20 13F-HR Wealth Alliance Advisory Group, Llc 12,347 12,347 0.00 209 216 3.35
2018-07-20 13F-HR North Star Investment Management Corp. 2,500 2,500 0.00 42 44 4.76
2018-08-02 13F-HR Sigma Planning Corp 0 17,017 0 298
2018-08-10 13F-HR OARSMAN CAPITAL, INC. 37,399 27,125 -27.47 633 474 -25.12
2018-08-14 13F-HR Patriot Financial Group Insurance Agency, LLC 450 450 0.00 8 8 0.00
2018-08-13 13F-HR Advisor Group, Inc. 81,558 68,019 -16.60 1,380 1,190 -13.77
2018-07-25 13F-HR Benchmark Capital Advisors 18,400 18,600 1.09 311 325 4.50
2018-08-13 13F-HR HONKAMP KRUEGER FINANCIAL SERVICES INC /ADV 950 0 -100.00 16 0 -100.00
2018-08-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 0 14,182 0 248
2017-01-13 13F-HR MetLife Securities, Inc 49,613 36,689 -26.05 725 525 -27.59
2018-07-25 13F-HR INVESTMENT PARTNERS LTD /OH/ /ADV 10,854 10,854 0.00 184 190 3.26
2018-08-13 13F-HR Stratos Wealth Partners, LTD. 15,380 16,080 4.55 260 281 8.08
2018-08-02 13F-HR Fiera Capital Corp 13,067 12,099 -7.41 221 212 -4.07
2018-07-11 13F-HR LUCAS CAPITAL MANAGEMENT 17,700 12,300 -30.51 304 215 -29.28
2018-08-14 13F-HR Centaurus Financial, Inc. 42,271 91,326 116.05 715 1,597 123.36
2018-07-25 13F-HR/A NWAM LLC 20,050 20,050 0.00 339 351 3.54
2018-08-13 13F-HR Laurion Capital Management LP 0 44,000 0 770
2018-08-13 13F-HR Wealthcare Advisory Partners LLC 1,735 1,739 0.23 29 30 3.45
2018-08-10 13F-HR Mosaic Family Wealth, LLC 1,755 1,755 0.00 30 31 3.33
2018-07-10 13F-HR COBIZ INVESTMENT MANAGEMENT, LLC 12,699 222
2018-08-13 13F-HR Neuberger Berman Group LLC 23,210 23,210 0.00 393 406 3.31
2018-07-18 13F-HR REILLY FINANCIAL ADVISORS, LLC 14,662 13,792 -5.93 248 241 -2.82
2018-07-23 13F-HR TOTH FINANCIAL ADVISORY CORP 27 28 3.70
2018-07-27 13F-HR/A WHITTIER TRUST CO 3,372 3,372 0.00 57 59 3.51
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 7,736 7,736 0.00 131 135 3.05
2018-08-09 13F-HR Private Advisor Group, LLC 0 23,906 0 421
2018-08-07 13F-HR IFP Advisors, Inc 114,866 118,343 3.03 1,944 2,070 6.48
2018-08-14 13F-HR Virtue Capital Management, Llc 1,000 0 -100.00 17 0 -100.00
2018-08-08 13F-HR First Allied Advisory Services, Inc. 25,645 21,896 -14.62 433 382 -11.78
2018-08-08 13F-HR Financial Advocates Investment Management 10,145 179
2018-08-14 13F-HR DEUTSCHE BANK AG\ 13 13 0.00 0 0
2018-08-13 13F-HR Baird Financial Group, Inc. 0 37,674 0 659
2018-04-16 13F-HR IFC Holdings Incorporated/FL 27,201 0 -100.00 449 0 -100.00
2018-07-16 13F-HR OTA Financial Group L.P. 24,038 420
2018-08-01 13F-HR Kovack Advisors, Inc. 13,503 0 -100.00 228 0 -100.00
2018-08-14 13F-HR FLAGSHIP HARBOR ADVISORS, LLC 0 4,257 0 74
2018-07-30 13F-HR Raymond James Financial Services Advisors, Inc. 48,240 37,783 -21.68 816 661 -19.00
2018-08-14 13F-HR AMERIPRISE FINANCIAL INC 354,386 404,936 14.26 5,976 7,084 18.54
2018-07-03 13F-HR Washington Trust Bank 8,866 8,866 0.00 150 155 3.33
2018-08-14 13F-HR Banco De Sabadell, S.a 2,330 2,330 0.00 39 40 2.56
2018-08-14 13F-HR Cetera Advisors LLC 0 14,485 0 251
2018-08-13 13F-HR RAYMOND JAMES & ASSOCIATES 25,884 26,765 3.40 438 468 6.85
2018-08-08 13F-HR USCA RIA LLC 16,628 291
2018-08-03 13F-HR AlphaMark Advisors, LLC 3,300 3,300 0.00 56 58 3.57
2018-08-14 13F-HR COHEN & STEERS INC 494,101 494,101 0.00 8,360 8,642 3.37
2018-08-14 13F-HR Cetera Investment Advisers 0 144,233 0 2,522
2018-05-09 13F-HR OPTIMUM INVESTMENT ADVISORS 0 150 0 3
2018-08-13 13F-HR Sym Financial Corporation 16,068 16,068 0.00 272 281 3.31
2018-08-13 13F-HR MML INVESTORS SERVICES, LLC 25,424 29,082 14.39 430 509 18.37
2018-08-14 13F-HR BANK OF AMERICA CORP /DE/ 274,966 316,691 15.17 4,653 5,539 19.04
2018-08-14 13F-HR MILLENNIUM MANAGEMENT LLC 25,527 30,810 20.70 432 539 24.77
2018-08-14 13F-HR ROCKY MOUNTAIN ADVISERS, LLC 20,000 20,000 0.00 338 350 3.55
2018-08-10 13F-HR NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 189,483 173,998 -8.17 3,206 3,043 -5.08
2018-08-10 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 95,147 95,147 0.00 1,609 1,664 3.42
2018-08-13 13F-HR NORTHERN OAK WEALTH MANAGEMENT INC 0 0
2018-08-01 13F-HR Northwest Capital Management Inc 11,720 11,744 0.20 198 205 3.54
2018-07-20 13F-HR Cornerstone Wealth Management, LLC 48,870 947,973 1,839.79 819 53,740 6,461.66
2018-08-14 13F-HR Valeo Financial Advisors, Llc 1,247 22
2018-08-07 13F-HR Lexaurum Advisors, Llc 72,243 0 -100.00 4 0 -100.00
2018-08-03 13F-HR Capital Analysts, Inc. 1,595 0 -100.00 27 0 -100.00
2018-08-01 13F-HR WELLS FARGO & COMPANY/MN 33,402 40,135 20.16 565 701 24.07
2018-08-13 13F-HR CCM INVESTMENT ADVISERS LLC 10,500 183
2018-08-15 13F-HR Bruderman Asset Management, LLC 8,374 8,436 0.74 142 148 4.23
2018-08-02 13F-HR D.A. DAVIDSON & CO. 10,805 13,494 24.89 183 236 28.96
2018-08-01 13F-HR Copperwynd Financial, Llc 10,033 175
2018-08-06 13F-HR Granite Investment Partners, LLC 11,502 11,757 2.22 195 206 5.64
2018-07-20 13F-HR Creative Planning 20,362 24,076 18.24 345 421 22.03
2018-08-08 13F-HR Hanson McClain, Inc. 85 87 2.35
2018-08-14 13F-HR STIFEL FINANCIAL CORP 14,993 20,483 36.62 253 355 40.32
2018-08-14 13F-HR GUGGENHEIM CAPITAL LLC 11,558 0 -100.00 196 0 -100.00
2018-08-08 13F-HR Homrich & Berg 68,829 68,963 0.19 1,165 1,206 3.52
2018-08-14 13F-HR FIRST FOUNDATION ADVISORS 37,526 18,545 -50.58 635 324 -48.98
2018-07-31 13F-HR Taylor Hoffman Wealth Management 11,488 11,488 0.00 194 201 3.61
2018-07-26 13F-HR REGIONS FINANCIAL CORP 500 0 -100.00 8 0 -100.00
2018-08-08 13F-HR LINCOLN NATIONAL CORP 18,874 24,891 31.88 319 436 36.68

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Related News Stories

PTY: The High Yield Looks Safe For Now

2018-08-23 seekingalpha
The fund's high premium is a definite risk, but it has proved persistent in the short-term.

These 15 Closed-End Funds Are Consistent Market Beaters - Part 2

2018-06-08 seekingalpha
Earlier this week I reported on the results of a screen for closed-end funds (CEFs) that have been beating the total return mark set by the S&P 500 ETF (NYSEARCA:SPY) for YTD, 1 year and 3 years. There are fifteen funds in that list among some 356 CEFs (I excluded tax-free municipal bond funds from the pool). In that article (Part 1), I discussed my view of the eight domestic equity funds that made the cut. (314-1)

Weekly CEF Roundup: DSE Cuts Distribution By -31%

2018-05-21 seekingalpha
The Weekly CEF Roundup will be put out at the start of each week to summarize recent price movements in closed-end fund (NYSEMKT:CEF) sectors in the last week, as well as to highlight recently concluded or upcoming corporate actions on CEFs, such as tender offers. Most of the information has been sourced from CEFInsight or the Closed-End Fund Center. I will also link to some articles from Seeking Alpha that I have found for useful reading over the past week. (6-0)

PTY: A 22% Premium Is Only For The Bold

2018-05-18 seekingalpha
The corporate debt sector faces some distinctive headwinds, which makes the CEF selection in this space critically important.

CUSIP: 72201B101